03.07.12
Expanding its intellectual property (IP) portfolio, Albion Laboratories, Clearfield, UT, has acquired hundreds of IP assets from the Procter & Gamble Company (P&G) and its NutriStar business. The transfer of the NutriStar brand, along with its global trademarks and worldwide patent assets, expands Albion’s already large IP portfolio. The agreement includes the transfer of 102 patents and 51 trademarks previously owned by P&G throughout the world. NutriStar is a patented, shelf stable powdered drink mix containing key micronutrients (including Albion’s Ferrochel iron, iodine and vitamin A). NutriStar has been clinically proven to improve micronutrient status of children, making them “taller, stronger, smarter,” according to the company.
P&G launched NutriStar in early 2000, targeting developing markets with the nutritional powdered beverage designed to help kids grow while also boosting mental alertness and performance. While lauded for both its clinical results and mission, P&G was not able to secure broad market adoption, despite heavily investing in extensive educational campaigns.
“We continue to have great passion for this product and the technology behind it, but we also clearly see that getting it into the hands of those who need it most calls for a very different business model,” said Jeff Weedman, vice president, Global Business Development, P&G. “We have been working with Albion Laboratories for several years and view this as a truly win-win-win arrangement. Good technology is now in the hands of those who know this field the best and are best positioned to leverage it to deliver maximum benefit.”
P&G launched NutriStar in early 2000, targeting developing markets with the nutritional powdered beverage designed to help kids grow while also boosting mental alertness and performance. While lauded for both its clinical results and mission, P&G was not able to secure broad market adoption, despite heavily investing in extensive educational campaigns.
“We continue to have great passion for this product and the technology behind it, but we also clearly see that getting it into the hands of those who need it most calls for a very different business model,” said Jeff Weedman, vice president, Global Business Development, P&G. “We have been working with Albion Laboratories for several years and view this as a truly win-win-win arrangement. Good technology is now in the hands of those who know this field the best and are best positioned to leverage it to deliver maximum benefit.”
